Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Michael

Showing results (911-920 of 1,111) with videos related to

Pageof 112
Sort By:
Obesity Surgery|June 8, 2006
Open versus laparoscopic Roux-en-Y gastric bypass: a comparative study of over 25,000 open cases and the major laparoscopic bariatric reported seriesKenneth B Jones, Joseph D Afram, Peter N Benotti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 25, 2012
The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelopeMark S de Souza, Silvia Ratto-Kim, Weerawan Chuenarom, et al.
Plos One|November 19, 2010
Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidateJeffrey R Currier, Viseth Ngauy, Mark S de Souza, et al.
Ebiomedicine|October 4, 2023
Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccineYifan Li, Mélanie Merbah, Suzanne Wollen-Roberts, et al.
Menopause (New York, N.Y.)|August 1, 2023
Menopausal hormone therapy and change in physical activity in the Women's Health Initiative hormone therapy clinical trialsRita Peila, Xiaonan Xue, Michael J LaMonte, et al.
Virology Journal|July 2, 2024
Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AGLindsay Wieczorek, David Chang, Eric Sanders-Buell, et al.
NPJ Vaccines|December 14, 2021
SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responsesJoshua M Carmen, Shikha Shrivastava, Zhongyan Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2018
Quantifying resilience of humans and other animalsMarten Scheffer, J Elizabeth Bolhuis, Denny Borsboom, et al.
Plos Pathogens|February 6, 2016
Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env SequencesLawrence J Tartaglia, Hui-Wen Chang, Benjamin C Lee, et al.
Journal of Neuroinflammation|February 8, 2022
Neurocognitive impact of Zika virus infection in adult rhesus macaquesDenise C Hsu, Kesara Chumpolkulwong, Michael J Corley, et al.
Pageof 112

Showing results (911-920 of 1,111) with videos related to

Sort By:
Pageof 112
Obesity Surgery|June 8, 2006
Open versus laparoscopic Roux-en-Y gastric bypass: a comparative study of over 25,000 open cases and the major laparoscopic bariatric reported seriesKenneth B Jones, Joseph D Afram, Peter N Benotti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 25, 2012
The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelopeMark S de Souza, Silvia Ratto-Kim, Weerawan Chuenarom, et al.
Plos One|November 19, 2010
Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidateJeffrey R Currier, Viseth Ngauy, Mark S de Souza, et al.
Ebiomedicine|October 4, 2023
Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccineYifan Li, Mélanie Merbah, Suzanne Wollen-Roberts, et al.
Menopause (New York, N.Y.)|August 1, 2023
Menopausal hormone therapy and change in physical activity in the Women's Health Initiative hormone therapy clinical trialsRita Peila, Xiaonan Xue, Michael J LaMonte, et al.
Virology Journal|July 2, 2024
Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AGLindsay Wieczorek, David Chang, Eric Sanders-Buell, et al.
NPJ Vaccines|December 14, 2021
SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responsesJoshua M Carmen, Shikha Shrivastava, Zhongyan Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2018
Quantifying resilience of humans and other animalsMarten Scheffer, J Elizabeth Bolhuis, Denny Borsboom, et al.
Plos Pathogens|February 6, 2016
Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env SequencesLawrence J Tartaglia, Hui-Wen Chang, Benjamin C Lee, et al.
Journal of Neuroinflammation|February 8, 2022
Neurocognitive impact of Zika virus infection in adult rhesus macaquesDenise C Hsu, Kesara Chumpolkulwong, Michael J Corley, et al.
Pageof 112